AI-assisted Endotracheal Intubation

March 30, 2026 updated by: Clyde Matava, The Hospital for Sick Children

AI-assisted Endotracheal Intubation in Children and Neonates: A Prospective Randomized Controlled Simulation Trial

This study evaluates artificial intelligence (AI)-assisted videolaryngoscopy for endotracheal intubation in a simulated pediatric airway environment. Healthcare providers with varying levels of airway management experience will perform intubations on pediatric and neonatal mannequins using either AI-assisted videolaryngoscopy (larynGuide) or conventional videolaryngoscopy.

Participants will be randomized to perform intubation tasks using one of the two techniques. The primary outcome is the time required for successful intubation. Secondary outcomes include first-attempt success rate, number of attempts, airway visualization (POGO score), usability of the AI system measured by the System Usability Scale (SUS), and gaze tracking metrics evaluating user interaction with visual guidance.

This equivalence randomized controlled trial aims to determine whether AI-assisted videolaryngoscopy performs comparably to conventional videolaryngoscopy while potentially improving success rates and user experience.

Study Overview

Detailed Description

Artificial intelligence is increasingly being applied in clinical medicine, including airway management. Machine vision algorithms have recently been developed to recognize airway anatomy and provide guidance during endotracheal intubation.

LarynGuide is an AI-based system designed to guide endotracheal tube placement using real-time visual prompts during videolaryngoscopy. This study aims to evaluate whether AI-assisted intubation is equivalent to conventional videolaryngoscopy in terms of time required for intubation and whether AI guidance improves success rates or usability.

This prospective randomized controlled simulation trial will recruit healthcare providers with varying levels of airway management experience. Participants will receive a short training session with the AI system and then will be randomized to perform intubations using either AI-assisted videolaryngoscopy or conventional videolaryngoscopy.

Each participant will perform intubations on both pediatric and neonatal airway mannequins in a simulation setting. Outcomes including intubation time, success rate, number of attempts, POGO score, gaze tracking metrics, and user satisfaction will be collected.

The study will be conducted at the Hospital for Sick Children Simulation Centre in Toronto, Canada.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Any healthcare worker or trainee

Exclusion Criteria:

  • refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AI-assisted videolaryngoscopy
Participants perform simulated endotracheal intubation using videolaryngoscopy integrated with the AI guidance system
Participants perform simulated endotracheal intubation using videolaryngoscopy integrated with the AI guidance system
Active Comparator: Conventional videolaryngoscopy
Participants perform simulated endotracheal intubation using standard videolaryngoscopy without AI assistance.
Traditional intubation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time required for intubation
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
First-attempt success rate
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery
POGO score
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery

Other Outcome Measures

Outcome Measure
Time Frame
SUS score
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery
Translated POGO score
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery
Intubation status (good vs bad vs not started)
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery
Intubation instructions (push forward, pull back, etc)
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery
Laryngoscopy status & instructions (need to move right, need to move back
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery
Gaze duration
Time Frame: baseline, pre-intervention/procedure/surgery
baseline, pre-intervention/procedure/surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

March 25, 2026

First Submitted That Met QC Criteria

March 30, 2026

First Posted (Actual)

April 2, 2026

Study Record Updates

Last Update Posted (Actual)

April 2, 2026

Last Update Submitted That Met QC Criteria

March 30, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on AI-assisted videolaryngoscopy

Subscribe